Roundup: Thailand’s Mahidol University Begins VR Training on Infectious Disease Treatment and More Briefings
Mahidol University applies VR for medical training
Royal Mahidol University in Thailand has teamed up with Japanese VR company Jolly Good to start a virtual reality program that trains students in infectious disease treatment.
Based on a press statement, Jolly Good will provide the university with VR equipment and facilities that enable the self-production of VR-based instructional materials.
They will be featured in four educational faculties: Mahidol University’s Department of Tropical Medicine, Ramathibodi’s Hospital School of Nursing and Faculty of Medicine, and Center for Simulation Education at Chakri Naruebodindra Medical Institute.
An initial demonstration of VR educational materials will verify its effectiveness before it can be expanded to regional hospitals in Thailand.
Jolly Good notes that many doctors in Thailand do not receive adequate training or education in infectious diseases after they graduate.
“After the COVID-19 pandemic in Thailand, it was difficult for us to teach infectious diseases to students and medical staff. We were looking for new technologies to provide quality medical education. high quality and nowadays, Thai educators are paying more attention to VR”, Dr. Aongart Mahittikorn, associate professor in the Department of Tropical Medicine at Mahidol University.
The demonstration project was also supported by the Juntendo University Information Technology-Based IT Human Resource Development Project for Infectious Diseases and Community Medicine in Thailand and Southeast Asia.
Indira IVF to deploy Presagen’s AI to identify viable embryos
Indira IVF is deploying Presagen’s AI technology to identify viable embryos across more than 100 clinics in India.
Life Whisperer is an AI-based tool for analyzing images of patient embryos and assisting in the selection of embryos most likely to lead to pregnancy.
“We are delighted to be able to make this new technology available to all of our patients as part of their IVF cycle at no additional cost. This will ensure couples can receive the best possible IVF treatment and the greatest chance to start a new family sooner,” said Srinivas Madabusi, Indira IVF’s Director of International Sales and New Initiatives.
Genomics Thailand strengthens sequencing capacity
Genomics Thailand has received two high-throughput decoders from Shenzhen-based MGI Tech to enhance the genome sequencing capacity of 50,000 Thais and generate new biological insights into the genomes of 50,000 Thais. complex diseases such as cancer.
The DNBSEQ-T7RS MGI Sequencer is a four-chip sequencing platform that can generate 6 terabytes of data per day and complete up to 60 human genomes daily. The sequencing and automation platform was also recently selected by the Indonesian Ministry of Health to support the country’s National Genome Project.
The five-year Thailand Genomics Initiative aims to establish a comprehensive medical database of Thai locals to help researchers better understand their unique genomic complexity . The database will also be the foundation for the development of personalized diagnosis, drug selection and treatment in the areas of cancer, infectious diseases, rare and undiagnosed diseases, non-communicable diseases, and non-communicable diseases. pharmacological disease.
